EHA HIGHLIGHTS 2024 - LEUKEMIA ROUNDTABLE DISCUSSION: EFFICACY IN NEWLY DIAGNOSED PATIENTS WITH FLT3-ITD+ AML WHO RECEIVED CONTINUATION THERAPY